Drawing for TCR-GENERATOR

USPTO serial 79165086

TCR-GENERATOR

Reviewed by CopyMark Law Group

Reg. 4929673Status 404
Filing date
Status date
Registration date
Apr 5, 2016
Examiner
EVANKO, PATRICIA MALESARDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TCR-GENERATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, in particular polypeptides and proteins prepared by genetic engineering, namely, fusion proteins and nucleic acids encoding these polypeptides and proteins, cells, in particular body cells and cells of the immune system of mammals including human cells for scientific or research use; analytical kits used in industry and science for the purification or detection or immobilization of fusion proteins, fusion peptides or cells, in particular of body cells and cells of the immune system of mammals including human cells, essentially consisting of chemical reagents for scientific and research use; diagnostic preparations except for medical purposesSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations, in particular polypeptides and proteins prepared by genetic engineering, namely, fusion proteins, cells, particular body cells and cells of the immune system of mammals including human cells for medical purposes; diagnostic preparations for medical purposesSECTION 71 - CANCELLED—
042Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; services of a biochemical or pharmaceutical laboratory, in particular synthesis of recombinant polypeptides and proteins, cultivation and purification of cells, in particular of body cells and cells of the immune system of mammals including human cellsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 5, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 13, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 23, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 23, 2023INPCINVALIDATION PROCESSED—
Jun 21, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 21, 2022C71TCANCELLED SECTION 71—
Feb 18, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 4, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 29, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 6, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 6, 2016FIMPFINAL DISPOSITION PROCESSED—
Jul 5, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 5, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 30, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 30, 2015NPUBNOTICE OF PUBLICATION—
Dec 17, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2015ALIEASSIGNED TO LIE—
Nov 18, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 8, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 20, 2015CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 7, 2015RFNTREFUSAL PROCESSED BY IB—
May 22, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 20, 2015RFRRREFUSAL PROCESSED BY MPU—
May 20, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 19, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2015DOCKASSIGNED TO EXAMINER—
May 18, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance